BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6930631)

  • 1. [Present-day treatment of acute leukemia in children].
    Rumiantsev AG
    Pediatriia; 1980; (5):57-62. PubMed ID: 6930631
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current approaches to the treatment of lymphoblastic leukemia in children].
    Makhonova LA; Maiakova SA
    Pediatriia; 1980; (5):22-6. PubMed ID: 6930628
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunosuppressive effect of cytostatics].
    Umbetkulova EK; Liubimova LS; Udovichenko AI; Ermakova GL; Martynova VA
    Probl Gematol Pereliv Krovi; 1980 May; 25(5):23-7. PubMed ID: 6995972
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemoimmunotherapy in acute myelocytic leukemia.
    Holland JF; Bekesi JG; Cuttner J; Glidewell O
    Isr J Med Sci; 1977 Jul; 13(7):694-700. PubMed ID: 270473
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined treatment of leukaemias and reticuloses.
    Lancet; 1970 Oct; 2(7676):757-8. PubMed ID: 4195983
    [No Abstract]   [Full Text] [Related]  

  • 6. [Induction and interval treatment of leukemias in children and juveniles].
    Oehme J; Meyer-Beeck D
    Dtsch Med Wochenschr; 1969 Sep; 94(39):1993-6. PubMed ID: 5352272
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of reinductions in a modern protocol for the treatment of childhood acute lymphoblastic leukaemias. Analysis of the D-74 protocol (author's transl)].
    Ortega JJ; Javier G
    Sangre (Barc); 1981; 26(1):47-57. PubMed ID: 6942519
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term remission in the course of lymphoblastic leukemia treated according to the Paris 06 LA66 program].
    Mendeleev IM; Arkavina EA; Berliner GB; Trofimova NI; Polezhaev IuN
    Ter Arkh; 1978; 50(7):14-7. PubMed ID: 281013
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy of acute leukemia with drug combinations which include asparaginase.
    Leventhal BG; Henderson ES
    Cancer; 1971 Oct; 28(4):825-9. PubMed ID: 5286445
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute lymphatic leukemia in adults. Therapy and prognosis in comparison with acute myelogenous leukemia].
    Abbrederis K; Michlmayr G; Schmalzl F
    Med Klin; 1974 Mar; 69(10):427-31. PubMed ID: 4524609
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of acute lymphoblastic leukemia in childhood. Epicritical evaluation of 2 therapeutic regimes].
    Madon E; Cordero di Montezemolo L; Pastore G; Grazia G
    Minerva Pediatr; 1979 Jun; 31(12):909-14. PubMed ID: 288971
    [No Abstract]   [Full Text] [Related]  

  • 12. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children].
    Maiakova SA; Makhonova LA
    Vestn Akad Med Nauk SSSR; 1986; (5):15-7. PubMed ID: 3487897
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute myeloid leukemia in adults: experience at AIIMS.
    Raina V; Kochupillai V
    J Assoc Physicians India; 1983 Aug; 31(8):511-4. PubMed ID: 6581155
    [No Abstract]   [Full Text] [Related]  

  • 14. Selecting drug regimens in human leukemia.
    Hall TC
    Natl Cancer Inst Monogr; 1971 Dec; 34():145-51. PubMed ID: 5291098
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of complex treatment of adults with myeloblastic leukemia].
    Mazurowa A; Krykowski E; Robak T; Płuzańska A; Polkowska-Kulesza E; Olszańska-Skorek T
    Pol Tyg Lek; 1980 Aug; 35(31):1187-9. PubMed ID: 6933424
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurological complications during treatment of childhood cancer: mind Wernicke encephalopathy.
    La Spina M; Catania R; Lo Nigro L; De Grandi C; Palmucci S; Di Cataldo A
    Pediatr Hematol Oncol; 2010 May; 27(4):320-3. PubMed ID: 20426524
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute juvenile lymphatic leukemia in the Netherlands: study ALL II, 1973-5; Foundation Dutch Childhood Leukemia Study Group].
    van der Does-van den Berg A; de Koning J; Reerink H; de Vries JA; van Zanen GE
    Ned Tijdschr Geneeskd; 1976 Sep; 120(36):1521-8. PubMed ID: 1067480
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
    Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
    Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of high-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84.
    Ortega JJ; Javier G; Olivé T
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():72-83. PubMed ID: 3214043
    [No Abstract]   [Full Text] [Related]  

  • 20. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M
    Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.